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New DNA Lab at the Seed Science Center
By dan Curry, Iowa State University Seed Laboratory manager
the Iowa State Seed Lab is expanding its facilities by opening a genetic testing laboratory 
using polymerase chain reaction techniques (pCr). Some participants in the Seed and food 
Industries require this sensitive test to determine if genetic modified organisms (gmo’s) are 
present in their products. 
pCr technology amplifies a target dNA sequence if 
it is present in a sample. the established qualitative 
pCr test determines whether or not the target gene is 
present.  the real-time pCr procedure determines if the 
gene is present and also the relative amount. the test 
is frequently used to detect the presence of sequences 
created through the use of biotechnology.  If the sample 
contains a genetically modified gene, thousands of copies 
of part of the gene will be made, thereby allowing the 
analyst to detect the gene. the Seed Lab will be using 
both traditional and real-time pCr in its analysis.  
the ISU Lab is not new in genetic trait testing, however. for almost ten years the ISU Lab 
has been providing genetic trait testing using a variety of different techniques. these 
techniques include bioassays, eLISA (enzyme-Linked Immunosorbent Assay) plate and eLISA 
strip technologies. the bioassay is a simple test that determines if the seed lot is herbicide 
tolerant.  By soaking the seed or seedlings in herbicide solution, and then observing how the 
seedlings    
 react to the herbicide, an analyst can decide if the seed
lot contains the gene in question. this is an excellent, low-cost method for seed companies 
to insure that seed they are selling has a high enough frequency of herbicide resistance.
 
 the eLISA method is based on detection of specific proteins rather than the genes that code 
for them. two application procedures use the method. the first uses a plastic plate with 96 
wells that contain an antigen for the target protein. tiny liquid samples from the seed or 
plant tissue are placed in the wells. If the target protein is present, the wells change color. 
If not, the solution washes out and there is no color change. this method works well in a 
lab environment, since it requires the use of a computer-controlled plate reader, a sterile 
environment, and lab equipment such as a multi-channel pipette.
the other eLISA method uses a lateral flow absorbent strip. when this strip is placed in 
a solution of plant material and water, it will detect whether a protein from a particular 
genetic protein is present in the sample. this system works well in non-laboratory settings 
such as crop fields, farm elevators, and other points of commerce where a quick, low-cost 
determination of gmo presence is needed.
the new dNA lab is located in the Northwest corner of the Seed Science Center.  dr. Satish 
rai coordinates the work.  Anania fessehaie has been hired as a research scientist to develop 
new technologies and to test the service samples that require pCr testing. Yes, the pCr lab is 
now “up-and –running” and ready to serve the needs of the customers.  
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Higinio Lopez-Sanchez
Graduate Student in Seed Science.
Background: 
Higinio has a 
bachelor’s degree 
from Universidad 
Autonoma 
Chapingo 
in General 
Agronomy 
in 1988, and 
master’s degree 
from Colegio de Postgraduados in Seed 
Production in 1994.  The Colegio de 
Postgraduados is a Mexican university 
system for agricultural postgraduate 
education and research that spans a 
number of campuses and the full array of 
agricultural disciplines. 
Current: Higinio has finished his Ph.D. in 
Crop Production and Physiology, with a 
specialization in Seed Science, and Minor 
studies in Plant Pathology.
Research: Higinio studied the corn pollen 
flow for transgenic varieties and the 
resulting outcrossing, specifically:
•  Pollen flow in open fields
•  Pollen flow in corn fields
•  Outcrossing in corn fields with 
   different  pollen densities
Personal Comments: I have found in 
Seed Science Center what I expected to 
find in ISU. excellent conditions to work, 
to study, and to learn. I have obtained 
more than the necessary knowledge to go 
back to my country and do a better job. 
Satish Rai
 Laboratory Scientist
Satish was born and 
raised in a farming 
family on the plains 
of the ganges in 
eastern Uttar pradesh 
in India.  He holds 
an mS from Banaras 
Hindu University in 
agricultural extension 
education and 
communication.  He received master’s and 
ph.d. degrees in plant Sciences from North 
dakota State University, specializing in plant 
molecular genetics. After graduation, he 
worked as Natural Sciences and engineering 
research Council of Canada visiting scientist 
with the eastern Cereal and oilseed research 
Centre of Agriculture and Agri-food Canada. 
He set up a marker lab, trained the lab 
technical staff, and was involved with key 
projects in the identification and mapping of 
molecular markers linked to major genes for 
high seed protein, white mold tolerance, and 
maturity in soybean. the markers were to be 
used in molecular breeding, the improvement 
of traits by selection for closely linked marker 
genes. 
In 2000, dr. rai joined Limagrain Canada 
Seeds Inc, LCSI, as a molecular marker Lab 
manger to manage a molecular breeding 
program for canola. LCSI was a joint venture 
between Limagrain and monsanto. the 
acquisition of Limagrain’s share of LCSI by 
monsanto resulted in a partial change of his 
responsibilities.  He accepted additional new 
duties as a manager for the genetic purity Lab. 
In January 2004, dr. rai moved to 
pennsylvania State University as a Visiting 
faculty member to develop dNA detection 
methods for high risk pathogens. the 
experience provided him with exposure to 
some new dNA detection technology. In April 
2004, I moved to Seed Science Center, Iowa 
State University as a manger and Scientist for 
dNA detection laboratory. the laboratory will 
develop and employ new dNA methods for 
testing of biotech and non biotech traits, dNA 
fingerprinting. 
Currently, the Seed Science Center dNA 
detection laboratory has a number of 
projects underway to develop and implement 
cutting edge dNA technology for the seed 
industry. for example, we are collaborating 
with the seed pathology group at georgia 
tech to develop a dNA magnetic capture 
probe system for identification of seed born 
pathogens. 
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S e e d  S C I e N C e  C e N t e r  p r o f I L e S 
Risks and benefits of growing Pharmaceutical corn in the Corn Belt
dr. dermot Hayes, department of economics, Iowa State University
Should Iowa continue to allow the production of pharmaceutical corn? A possible benefit of this activity is the economic activity 
associated with the growth and possible production of the pharmaceutical products. A possible harm that might come about 
is the possibility that some commodity corn grown near a field of pharmaceutical field might possibly be contaminated. It is 
very unlikely that contaminated commodity corn would ever pose a health risk. this is true because many of the pharmaceutical 
products that are grown or which might be grown in Iowa are safe for human consumption. However it seems highly likely that 
the detection of pharmaceutical corn in a load of commodity corn would result in a lower price for commodity corn. 
the purpose of the research summarized here was to put a financial value on the risk associated with cross contamination. there 
is a host of possible ways in which pharmaceutical corn might contaminate the food supply. obvious examples include accidents 
in transportation or contamination caused by terrorism. these possible causes exist wherever pharmaceutical corn is grown and 
are not specific to the Corn Belt. So we narrowed our focus to causes of contamination that were specific to the Corn Belt. we 
focused on wind blown dispersal of pollen from pharmaceutical fields to receptive corn in commodity fields.
the possibility of pollen caused contamination has been a concern for the USdA Animal and plant Health Inspection Service 
(ApHIS) for quite some time, and this organization has put a host of restrictive measures in place to make sure that this 
contamination does not happen. our specific task was to estimate the probability that cross contamination might occur even if 
these ApHIS requirements were followed. 
Clearly we are dealing with very small probabilities and we also need a method to put a financial value on risk. to get round these 
issues we found the fair value of an insurance product that paid for the destruction of all nearby commodity corn in the event of 
an unusual wind event that might in theory cause any nearby field of commodity corn to have one contaminated kernel in any 
forty acre field.
we do not yet know how farm pollen will move under all possible wind conditions and if we wait for experimental plot data 
showing a 1 in 10,000 wind event we might possibly have to wait for many years before nature provides us with this natural 
experiment. Instead we decided to develop a simulation model that showed how far pollen would move under various 
conditions and then compare this model prediction against the data that we do have. 
mark westgate a professor in ISU’s agronomy department provided us with experimental data on wind flow and pollen 
movement and we discovered that the simulation model replicated this data quite well. Next we ran the simulation model 
thousands of times using a distribution of wind speeds taken at Boone airport. this experiment allowed us to create as many 
“years” of data as we needed and in so doing capture likelihood of a very unlikely wind event during pollination.
In order to find the fair value of the insurance product we then assumed that each field of pharmaceutical corn would have a 
weather station, and we then insured against the detection by this station of a wind event strong enough to move the pollen 
over the set backs imposed by ApHIS. we also took into account the other protective measures such as de-tasseling, the use of 
male sterility and temporal separation that the industry has used to minimize contamination. our insurance contract triggered if 
there was a possibility that one kernel in any of the surrounding 40 acre fields was fertilized by pharmaceutical pollen.
the results suggested that the fair value of such an insurance contract was only $11 per acre of pharmaceutical corn. this 
suggested that the various ApHIS requirements were successful. However, our results do indicate a very-very small possibility 
that such contamination might occur especially if the producer did not use male sterile lines and de-tassle. ApHIS has adopted a 
zero tolerance against this kind of event and our results (and the results of any probability based experiment) indicate that these 
zero tolerances cannot be met. these findings may have implications for the production of pharmaceutical corn under current 
regulations, the formulation of changes in the formulation of new government regulations, or the way that risks and benefits 
associated with pharmaceutical corn production are communicated to the public.   
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 AmAteur PhilosoPhy Corner
Attitudes to Biotech
By paul Christensen, Coordinator of distance education, Seed Science Center
Introduction
the seed industry is influenced and shaped by attitudes and decisions concerning the use of the products of biotechnology, and the use of 
variety ownership. many of us in the industry tend to approach the value of seed, varieties and biotechnology from the viewpoint of their 
usefulness to people.  In our efforts to apply science, we in the technical community need to be aware that our attitudes will only take us so far 
and are not shared by all.  Although view points vary greatly, some of them have a more rational, philosophical, basis and can be grouped into 
categories that make them easier to discuss.  In this article I will focus on two ethical categories: utilitarian and human rights. these categories 
include the most effective arguments in favor of biotechnology and variety ownership.    
we need to be aware of the kinds of opinions about the industry so that we can think about them and react to them. In many cases decisions 
about seed or biotech will be made on the basis of economic or legal arguments, but in this discussion we will accept questions about why we 
should use market prices or some particular law.  Are those criteria ethical? Can they be communicated effectively?
many attitudes toward biotechnology and varieties are about ownership, and the impact of ownership and possessiveness on individuals and 
society.   Some are about the relationship between mankind and nature.  Some are about the relationship between individuals and government 
institutions, and relationships between science, government and the public. Arguments narrowly focused on technology will not address these 
broader concerns. As scientists and industry members, readers we may feel comfortable with the positive or negative value of seed for society, 
but broader definitions of knowledge, value and ethics add complexity to the public discussion.  
the core beliefs of our developed world grew out of a thought revolution which came to prominence in the 18th century which described 
human as rational, independent beings. the traditional thought that preceded the enlightenment world conceived of the individual as a being 
who depended on institutions, mainly church and monarchy. this core modern world view is associated with a synthesis of two kinds of ethical 
systems: utilitarianism and human rights, both of which associate value with the individual.
Utilitarianism
In utilitarian systems decisions are made based on the greatest future good for the greatest number.  Variations of utilitarianism define “good” in 
different ways, but they are all based on evaluating the outcomes of decisions based on their impact on individuals: individual pleasure, absence 
of pain, intellectual pleasures, etc. Some variants apply utility as a means of making individual decisions; some apply utility to the process of 
constructing the rules for society.  
In the utilitarian system as applied to social rules, the market economy and the rules and institutions that support it can be justified because 
they maximize the good of society as a whole (at least to the extent that good and output coincide). this utilitarian justification of the market is 
counter-intuitive: the self-interest of individuals leads to mutual benefits.  Certain ideal conditions are required for the market to maximize social 
benefits (Arrow. Social Choice and Individual Values. 1951), and those conditions are frequently not fulfilled.  Understanding of the requirements 
for free markets provides a basis for the role of government in a market economy.  government assures that the conditions for free markets exist, 
or where they can not exist, maximizes society’s benefits through other interventions or institutions. 
Utilitarian arguments provide the basis for cost-benefit approaches to the evaluation of biotechnology.  In this perspective, the benefits to 
society of the use of biotechnology must outweigh any negative consequences of its use, and net value of use must be greater than of non-use. 
It is not necessary that negative consequences be zero, or that positive benefits outweigh negative consequences for each individual or each 
minority group.
Capital markets also help maximize the economic benefits of society in the exchange economy, and utilitarian ethics provide one of the major 
lines of reasoning in support of capitalism. Utilitarian arguments provide one basis for the creation of intellectual property rights as a tool for 
society to use to provide incentives for inventors to create new technology.  they provide the basis for plant variety protection laws and the use 
of patent protection for the products of biotechnology and plant varieties. 
Some of the main problems of utilitarian ethical systems are the difficulty of deciding upon a measure of utility, the difficulty of knowing future 
consequences, the difficulty of calculating net social value, and the issue of distribution of benefits. Utilitarian arguments have been made 
against the capitalism and the market economy also.  most relate to the distribution of benefits. the most forceful are associated the concept 
that benefits are “worth” more to the poor than the wealthy, and that maximizing output is the wrong measure of utility.  this kind of argument 
forms the utilitarian rational for social safety nets.  the strongest forms of the position have been associated with socialist governments, and 
have been somewhat discredited by the organizational failure of socialism, and the empirically observed inability of socialism to solve long-term 
capital allocation problems in ways that assured high net benefits to citizens.   
Utilitarianism is not an empirical theory of value, but the impartial rationality of empirical or scientific processes fits well with the impartial 
rationality of the utilitarian analysis and accounts for the tendency for scientist to use utilitarian arguments. the confidence of scientist in 
understanding chains of causation tends to overcome, for them, the arguments about the difficulty of predicting the future. 
Human rights
Human rights provide the basic philosophical underpinning of democracy.  Individuals have a right to participation in government.  the list of 
recognized human rights can vary from philosopher to philosopher and person to person.  
the conceptualization of the founding fathers of the American and french revolutions were natural rights.  they thought that the human 
individual had certain rights by his nature.  property and voting rights were included, as well as certain auxiliary rights that assured that 
participation in government was meaningful (the right to free speech, association, etc.) rights place weight on the present. ends do not 
necessarily justify means. 
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In this conceptualization, participation in the market economy is an exercise of individual property rights.  the value of the market 
is not because of the social utility that it achieves, but because it provides an outlet for the individual’s freedom of expression.  
In this philosophical system, intellectual property rights are conceived of as a creator’s right to the fruits of his labor.  
In the rights-based system, an individual has a right to trade in biotechnology as long as it does not impinge in some way on the 
rights of others. the unintended presence issue can be important.  Unintended presence may impact the rights of others, depending 
on the list of rights that are accorded to individuals.  
Kantian rights  
Kant provided another explanation for individual rights, “respect for persons.” the Kantian philosophy was a very elaborate derivation 
of something very similar to the Christian golden rule “do unto others as you would have them do unto you.” Although Kantian 
philosophy seemed to provide the individual most of the same considerations as natural rights, it did so in a way that the nineteenth 
century monarchies and governments of europe found more acceptable and controllable. Natural rights are inalienable: they can 
not be relinquished by the individual. Kantian rights are compatible with individuals voluntarily accepting traditional authority. In 
practice the association between authoritarian government and Kantian rights was subject to misuse then rulers saw acceptance 
where none existed.  
In Kantian ethics, poverty is a threat to personal integrity.  Biotechnology and especially public biotechnology gets some support a 
means to alleviate hunger.  
Kantian ethics is easily extended to rights of access to information, choice, and labeling issues.  Because the list of rights that can be 
derived from respect for persons is longer, Kantian ethics creates more problems for biotechnology than utilitarian ethics.
there are also rights-based arguments against free markets. for example, if I have a basic right to food or housing, to the extent that 
the free market renders me susceptible to not having food or housing, the market would be in conflict with my right. 
rights-based approaches seem simple to apply.  either the individual has a right in a particular situation or he does not. they 
don’t require a lot of information or analysis. the problems with rights-based approaches are that the list of rights can grow and 
contradictions between different rights (and different individuals) can appear.  Creating hierarchies of rights can be complex.
Conclusion
Although libertarians and utilitarians are likely to disagree with each other, it is difficult to conceive our current world without the 
dynamic tension between these two approaches to value and ethics in public decision making.  they both value the individual.
the valid use of market values is central to ethical application of cost-benefit analysis to biotechnology.  we have many kinds of 
reasons for accepting markets as ethical institutions: Utilitarian (despite market imperfections, markets frequently do deliver more 
benefits to individuals than alternatives), rights-based (liberty arguments for unimpeded market freedom), and Kantian (respect for 
autonomy requires that we avoid interfering with voluntary exchanges).  Accepting prices determined by markets, we have a well 
justified basis for the utilitarian analysis of costs and benefits of the use of biotechnology.  
the utilitarian efficacy of markets provides the main justification for intellectual property rights. these rights are not natural. they 
have to be created. without these rights allocation of capital to the creation of information would not be rewarded.  without the 
rewards capital will not be assigned to the creation of information in a free market.  without information, the public will not get the 
benefits that new information can create.  ownership rights will restrict the use of technology and therefore the benefits from its 
use, but at a level higher than is possible under public funding. public creation of knowledge is an alternative but has been found 
to allocate knowledge creation capital inefficiently, and does not solve the problem of how to reward the development of new 
information into working technology.      
rights allow for differing kinds of thought processes which can not all be “rational” in the same frame of reference, but placing value 
on individuals and their rights is very important to the modern world.  respect for the value of individuals underlies our representative 
government and gives collective decision-making a degree of legitimacy, but respect for human rights can sometimes be messy. 
Labeling can allow choice, but mandatory labeling has a cost that has to be borne by all.  How does one balance the right of one 
individual to choice, perhaps arbitrary choice, with the right of all individuals to refuse to pay a mandatory “tax” to allow that choice? 
How does one balance the right of one person to free speech about biotechnology when the lively hood or wellbeing of others is 
threatened by statements that can not be confirmed?  In practice, such decisions become the subject of collective choice, where at 
the margin the majority of lawmakers are likely to use utilitarian arguments to decide what constitutes a legal right, but that does 
not answer the question of the moral right.  
rights-based approaches to biotechnology and intellectual property should be given due consideration, even though many in 
the scientific community find some of them uncomfortable (excluding some rights established by long precedent in the academic 
community), and the proliferation of rights can logically lead to social or ethical gridlock when rights conflict.  
the division between utilitarian and rights-based approaches to decision making runs through most public discussion of 
biotechnology and intellectual property rights. recognizing these positions can be useful for those participating in the debate. Use 
of a utilitarian argument with a person who strongly believes in Kantian rights may not be productive. It may be more productive to 
make the utilitarian argument to his friends and neighbors.   
In coming issues, we will go beyond ethical values based on individuality to see that there are philosophical positions on the 
understanding of reality, the relationship between mankind and nature, and the relationship between the individual and society 
which also play a role in the debates about biotechnology and intellectual property rights. we will consider whether taking the basis 
of value away from the individual creates risks for individuals that will ultimately be found to be unacceptable.   
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2004 BIOSAFETY NEWS HEADLINES: Looking back
By dr. paul Christensen and dr. Jeff wolt
europe leads the world in news relating to genetically engineered or modified crops
eUrope
- Spain leads europe with greater than 50,000 ha planted to Bt maize varieties.
- Numbers of gm field trials continue to decline.  
- Labeling laws for transgenic food come into effect. eU states that the reason for labeling is to allow for personal preferences, not to   
  assure food safety. 
- eU regulatory logjam breaks.  Several new traits approved for consumption.  
 * oilseed rape variety gt73 for food
 * monsanto’s NK603 for feed and industrial use 
 * Bt-11 sweet corn was approved as food in the UK, but Syngenta chose not to sell it.
- one new trait is approved for planting 
 * t25 herbicide resistant corn in great Brittan
 * mon810 was approved for planting in the eU (food use had been approved several years earlier)
- And several new Bt varieties were approved for release in Spain.
- results from coexistance studies confirm that farms adjacent to gmo production can meet eU tolerances for adventitious presence of  
  traits in grain. 
- problems continue with the eU ability to enforce regulatory uniformity.  Several countries have bans. 
- the Swiss government rejected a proposed national ban. 
- 21st annual British social attitudes report: opposition to genetically modified (gm) foods has plummeted since 1999. then 52%    
   thought  that gm foods should be banned, even if prices suffered as a result; in 2004 less than a third (29%) agreed. 
 * It appears that the consultation process of late 2003 overestimated opposition.
- “It is the way the crop is farmed, not the crop itself, that determines its effect on biodiversity.” says Jeremy Sweet, scientific coordinator
  of a four- year study “Botanical and rotational Implications of genetically modified Herbicide tolerance” (BrIgHt) in the United  
  Kingdom.
 * Study includes weed density in assessment of impact on biodiversity
- US submitted a suit on the eU position on biotech food trade
USA
- monsanto decided not to market roundup ready wheat because of wide concerns about the impact on export markets. 
- USdA-Biotechnology regulatory Service, BrS receives 20 permit applications for transgenic crops expressing pharmaceuticals,  
  industrials, value added proteins, or for phytoremedation; 4 applications are withdrawn, and 11 plantings occur in 9 states for a total   
  of  45.35 acres.
- risks of biopharma crops were in the news more than other genetically engineered varieties.  Union of Concerned Scientists released  
  “A growing Concern,” asserting that the appearance of approved traits in seed had implications for the control of biopharma crops.  
- grain producer opposition to biopharma rice leads Ventria to abandon California for missouri, but grain producer opposition remains.
- BrS initiates an environmental Impact Statement as a precursor to new rule-making for transgenic products.
- evidence for long-distance transport from seed production fields leads BrS to seek further input into the deregulation of herbicide 
  resistant bentgrass.
- the cost of government approval continues to rise as regulators tighten up after Starlink and prodigene events.
- Sales of some US grain products continue to be suppressed by buyers choosing non-gm sources  
AfrICA
- discussion and trials continue. momentum builds for approvals on the basis of potential productivity gains. 
- Uganda introduced biotech regulatory legislation. 
- Zambia and Angola refused relief corn containing gmos.  Concern was with escape to local corn populations and with human health 
  concerns. 
ASIA
- Several countries continued testing of gm products, including canola in Australia.  
- Use of Bt cotton spreads rapidly in China and India.  Unapproved varieties spread beyond government control in India. 
- Korea adopted testing standards for importation of gm grain
- China continued testing of gm rice.
- the area of Bt corn continued to grow in the philippines after approval for planting in 2003.  media reports by terje traavik that a   
  gmo corn variety may have caused respiratory ailments in some filipino tribesmen were not confirmed.
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LAtIN AmerICA
- Argentina approved gA21 herbicide tolerant corn for planting.  for the first time, the government approved a trait for planting in   
  Argentina prior to approval for food use in europe.
- Argentina approved a new 10 year strategic plan for the local development of biotechnology.
- Brazil passed a new biosafety law.           
- Brazil missed the opportunity to approve rr soybeans for the 2004 planting season, but the legislation went forward.  planting was  
  allowed under an executive order from the president.  
- mexican lawmakers approved a new law to regulate genetically modified crops.  It was criticized on the basis of the impact of gm   
  traits on biodiversity.  
- Scientists continued to look for gm traits in indigenous varieties of corn in mexico, following planting of imported grain for seed, but 
  nothing was found.  A NAftA environmental panel from Canada, the United States and mexico recommended in october that mexico 
  adopt strict measures to control imports of genetically modified corn for food use. the recommendation was based on an assumption 
  of zero tolerance. Some conclusions were based on socio-cultural issues. U.S. government said NAftA report on genetically modified 
  corn was “flawed”
- CImmYt sowed first transgenic wheat field trials in mexico
CoNCLUSIoN
- during 2004 no sickness was linked to the use of the products of genetic engineering that had been approved for use as food.  the    
  area of use continues to expand.
- the existence and extent of environmental damage depends of the objectives established for the environment, the definition of   
  sustainability.  the changes in the environment that were reported are mostly associated with changes in agricultural practice.  Little 
  new was reported in the way of impacts on non-target organisms. reductions in the level of pesticides use per unit output continued. 
- the extension of the use of biotechnology does produce changes in society, the economy, and the lives of some individuals, as does 
  other technology.  Biotechnology coupled with intellectual property does extend the market economy into areas that were    
  previously beyond human control and extend the role of corporations into those areas. Change does create some winners and  
  losers. these changes are not BIgmApS within primary area of focus, but it does appear that those nations that allowed the process of 
  commercial plant biotechnology to go forward in a well regulated manner in 2004 did not have economic or social problems with the 
  technology that made a lot of news. 
DEvELOpmENT OF IN-LINE FLOW mETEr
Yuh-Yuan Shyy and Manjit Misra
The US Patent office issued two US patents (US 6,973,843 and US 6,805,014) to Drs. 
Yuh Yuan Shyy and Manjit Misra of the Seed Science Center. The patents were for their 
invention of a method for measuring the flow rate of a continuous flow of material, and an 
in-line continuous flow meter. These are their fifth and sixth US patents since they started 
working together at the Seed Conditioning Facility and Computer Technology Laboratory 
in 1984.
                                                                                                                                          
The invention can increase operating efficiency and improve quality during the condition-
ing of seeds (or processing of any other similar valuable granular products). It does so by 
facilitating the monitoring and managing of material flow at different check points in real-
time.  With the increasing value of seed 
using GMO traits and high value treatments, such management decisions can 
result in significant cost savings.  Among other applications, the manager can 
use the meter to avoid mixing of GMO and non-GMO products, and to make 
real-time measurements for use in management decisions, of the capacity 
and the discard percentage from various conditioning machines.  Before this 
invention, no real-time flow meter was available on the market that meet the 
criteria of minimum damage to seeds, accuracy of measurement, low cost, 
and feasibility of physical installation in existing operations.
By meeting these criteria, this innovative flow meter will find many applica-
tions in the conditioning of seed and other granular value-added products.
The technology is available for license from Iowa State University.  Drs. 
Shyy and Misra will demonstrate the flow meter under real dynamic condi-
tions at the Seed Conditioning Facility at ISU campus.  Further develop-
ment, based on the results of the tests, will make the unit more robust and 
clarify the calibration procedures. 
You can find out more information on licensing from ISU Research Founda-
tion Inc. (http://www.techtransfer.iastate.edu/).  For any technical questions, 
please contact either Dr. Shyy  (yshyy@iastate.edu or  Dr. Misra (mkmis-
ra@iastate.edu).
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2004/2005 Seed Conditioning Workshops
Dr. Kamal M. Adam and Mr. Alan Gaul. Former and Current Coordinators of the
Seed Conditioning Research and Training Program
 
The Seed Science Center held sixteen seed conditioning workshops over the past two years.  A total of one hundred 
eighty-four seed industry attendees came from Iowa, Nebraska, Illinois, Missouri, Wisconsin, North Dakota, California, 
Minnesota, Mississippi, and Pennsylvania. Workshop topics included seed corn and soybean seed conditioning, gravity 
separation, color sorting, and seed applied insecticides.  
Corn Conditioning Workshops:
 Two five day corn conditioning workshops were offered each summer.  The first session focused on seed 
corn plant design in which several speakers were invited to speak about seed corn plant design topics.   The second 
session covered harvesting, drying, shelling and bulk storage.  The third session covered hands-on-training with corn 
conditioning equipment where attendees were allowed to have intensive hands-on interaction with a variety of seed corn 
conditioning equipment.  Session four focused on seed corn treatment and packaging, also with hands-on practice.  In 
this session speakers from major pesticide and pesticide equipment companies spoke about their products.  Session five 
covered the quality assurance including laboratory tests.
Soybean Conditioning Workshops:
 One, three and a half day, soybean conditioning workshop was 
conducted each summer.  The workshops included four major sessions.  
As in the corn workshop the first session was devoted to soybean plant 
design.  The individual topics were covered by several professional 
speakers from the seed industry.  The second session was focused on 
harvest and conditioning with intensive, hands-on training with variety 
of soybean conditioning equipment, including color sorters. The third 
session was focused on soybean treatment and packaging. Equipment 
and chemical supplier representatives presented information on new 
pesticides treatments and new application equipment.  We also had 
presentations on new emerging productivity technology such as robotic 
palletizers.  Session four focused primarily on quality assurance.
Gravity Tables:
 A total of five one-day corn and soybean gravity table workshops 
were conducted over the past two years.  They were focused specifically 
on the adjustment, operation, and effectiveness of the gravity table for 
upgrading seed quality.  We offered intensive hands-on-training and 
troubleshooting for four gravity tables.  The attendees learned how to 
measure the  performance and capacity of a gravity table.
Color Sorting Workshop:
 Color sorting is an emerging technology that is expected to revolutionize the corn and soybean seed conditioning 
process. It adds value in a way that none of the conventional equipment is capable of doing. By use of different 
backgrounds and wavelengths the sorter can make fine distinctions 
that are associated with quality. The hands-on training was provided 
by the equipment manufacturers’ representatives.  They helped 
tremendously in addressing the attendees’ questions and concerns.
Seed Applied Insecticide Workshop:
This was offered as a “one time” conditioning workshop topic 
in 2004.  The workshop had the highest attendance of any single 
workshop offered during the past two years.  
Additional Notes for 2006:
The ISU seed conditioning workshop series will be offered again in 
2006.  The program will continue to offer “hands on” training with 
typical seed conditioning equipment in a small group environment. 
The soybean and corn workshops will be configured in two separate 
sessions to accommodate different experience levels and time 
constraints.  A new variation of our traditional seed corn conditioning 
workshop is being offered to cover specific topics of interest for 
research operations.  The color sorter workshop has been extended to 
provide time for more detailed operator training on specific brands.  
A dedicated workshop for commercial popcorn conditioning will 
also be offered in 2006.
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Biotech Trait Detection Workshop
Organized by
The International Seed Testing Association
Iowa State University; Seed Science Center
Pioneer Hi-Bred; GET Lab
 
Date: 8th – 10th, May 2006
Iowa State University
Seed Science center
Ames, IA 
DAY 1
8:00 - on  registration  
8:30 – 9:00 welcome  IA State & pioneer 
9:00 - 9:50 from the Seed Lot to the testing Lab: designing a Sampling & testing Scheme I Jean-Louis Laffont (pioneer)  
            & Kirk remund (monsanto)
10:00 - 10:50 from the Seed Lot to the testing Lab: designing a Sampling & testing Scheme. Jean-Louis Laffont (pioneer)  
            & Kirk remund (monsanto)
11:00 - 11:50 from the Seed Lot to the testing Lab: designing a testing Scheme II   Jean-Louis Laffont (pioneer)  
            & Kirk remund (monsanto)
12:00 - 13:00 Lunch  
13:00 - 13:30 from Seed Sample to dNA I: Upfront processing, tracking, & grinding        Kerry Hastings (pioneer; get Lab) 
13:30 - 14:00 from Seed Sample to dNA II: dNA Isolation, quantification & normalization     Jennifer Nau (get Lab), macherey-
Nagel 
14:00 - 18:00 Hands on lab: dNA isolation, Quantification & Normalization                   Seed Center & get Lab Staff
18:30 - 20:00 dinner/reception  
20:00 – 21:00 open discussion: contamination: testing laboratory’s enemy #1                        moderator: Beni Kaufman
DAY 2
7:00 – 7:50 Breakfast /Coffee  
8:00 – on  registration  
8:00 – 8:50 pCr technology; Introduction to polymerase Chain reaction                   Stratagene; fabrice magnino 
9:00 – 9:50 pCr technology for the detection of biotechnology traits: qualitative, semi quantitative and quantitative methods 
                        david pinero; get Lab
9:50 – 10:00  Coffee Break  
10:00 – 10:50 pCr technology for the detection of biotechnology traits: qualitative, semi quantitative and quantitative methods;  
              Jean-Louis Laffont (pioneer) & Kirk remund 
(monsanto)
11:00 – 11:50 from dNA Sample to data point:  Characterizing trait testing methods.         dave Hondred (pioneer)
12:00 – 13:00 Lunch  
13:00 – 16:00 Hands on: pCr (qualitative and real-time)         Sandi meyer (pioneer)/ fabrice(Stratagene)
16:00 – 16:50 data analysis and reporting         Sandi meyer (pioneer)/ fabrice (Stratagene)
17:00 – 18:00 dinner
18:00 - … Hands on: data collection documentation and analysis  
DAY 3
7:00 – 7:50 Breakfast /Coffee  
8:00 – on  registration  
8:00 – 8:50 Instrument, Assay, and process Validation                     Beni Kaufman (pioneer, get)
9:00 – 9:50 Challenges to pCr biotech trait detection                                                Satish rai (ISU)
9:50 – 10:00  Coffee Break  
10:00 – 10:50 Beyond Biotech traits; pCr technology for genetic purity and seed born pathogen  Satish rai/Anania fessehaie 
11:00 – 11:50  IStA & the gmo task force                                           Norbert Leist (IStA)
12:00 – 13:00 Lunch*  
13:00 – 17:00 Visit to pioneer Hi- Bred
17:00 - … formal dinner (sponsored by pioneer) and conclusion  
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What is Risk Assessment?
Jeff Wolt, Professor of Agronomy and BIGMAP Risk Analyst
the word ‘risk’ has become commonly overused and misunderstood in our daily lives. And our social fixation about “what are 
the risks?” has led to considerable difficulty in communication regarding technological innovations such as the use of modern 
biotechnology to produce genetically-engineered (ge) crops. the difficulty arises in part because we all understand risks “expe-
rientially” on the basis of what we are familiar with, our traditions, beliefs, and perceptions. But we can also understand “analyti-
cally” using the science-based process of risk assessment.
for many, ge crops are risky because they new and unfamiliar. we lack a basis of experience  by which to evaluate the risk. obvi-
ously, as individuals we do not have the same base of experience with ge crops; therefore, a scientist who has spent a career 
dealing with the tools of modern biotechnology will have a different base of experience compared to the everyday consumer 
of products developed with these tools. Social scientists have shown that risk perception changes depending on our familiarity 
with a technology – those experienced with the technology are less likely to perceive the technology as risky than those less
experienced with the technology.
A more objective way to deal with risk is “analytically,” through the science-based process of risk assessment. risk assessment 
is evaluation of the risk posed to human and animal health and/or the environment by the actual or potential presence and/or 
use of specific agents. risk assessment uses a factual base of information to define the effects of exposure of individuals or 
populations to materials or situations we encounter in our daily lives. evaluation of risk analytically through the process of risk 
assessment involves integrating diverse scientific information into a characterization of risk as a likelihood of harm under rel-
evant conditions of use or exposure.
Some dispute the objectivity of risk assessment, the objectivity of the science behind analysis of particular risks, and the con-
cept of objectivity itself.  these individuals tend to view risk from the standpoint of experience versus analysis, define risk on a 
more cultural or social basis, and accept cultural predispositions as valid criteria for the evaluation of risk, even when those no-
tions do not correspond to the observations of science. risk defined in these ways as a collective concept can not be quantified 
in the same way that science-based risk can, and it is not as amenable to analysis or discussion. the analytical conception of risk 
is more likely to lead to meaningful communication, compromise, and agreement about management.   
Broadly similar schemes of risk assessment that analytically address risk are used throughout the world in obtaining regulatory 
clearances for importation and cultivation of ge crops. A “risk assessment” in the context of ge crop regulatory clearances is 
comprised of a package of data characterizing the product and describing its exposure potential (where we will encounter the 
transgenic elements and their expressed products in the environment, foods, and feeds) as well as hazards these products may 
pose to human or animal health or to the environment. the risk assessment also involves interpretation of this weight of data to 
arrive conclusions regarding the likelihood of risk arising out of the intended deployment and use of the ge crop.
Countries that lack clear processes of risk assessment lack the means to address risk from this analytical perspective and there-
fore lack a sound means to counter the public’s lack of experience with the technology. 
even when risk assessment is used as a means to address questions of risk, there will always remain the challenge of balancing 
analytical versus experiential perspectives of risk. Sound, well-communicated principles for the use of science-based risk assess-
ment are a critical step to balancing scientific understanding of ge crops and their safety with public perceptions of risk.
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Dr. Wes Jamison’s presentation at the showed us how a group may be able to intentionally use existing habits to change 
the way that individuals react to biotechnology.  In this case, the reaction of individuals to scientific information is 
influenced by pre-existing social and cultural beliefs  
Wes presented examples that show the divergence between the probabilistic formal scientific characterization of risk 
and the perception of risk. The divergence is so frequent and substantial that he questions the use of the word “risk” for 
the scientific assessment and preferred to use it instead for the perception of risk.  For consistency with other articles in 
our newsletter we will use risk in the analytical sense here, a certain probability of the occurrence of unfavorable events. 
Wes said “risk is a socially arrived at understanding,” emphasizing the community nature of risk perception.  Because 
risk perception exists in a group it is inherently multicultural.  Some view the scientific assessment of risk as just one in 
a galaxy of risk perceptions.  
Wes used a bridge as analogy to illustrate the connection between the scientific assessment of risk and risk perception.  
He used a particular bridge, the bridge over the Tacoma narrows that collapsed on Nov. 7, 1940 in light winds that 
reinforced the natural harmonics of the structure.  He asserted that if organizations can 1) find underling anxieties or sources of confidence about 
hazards, that they can 2) use them to amplify or dampen the perception of risk and disrupt the connection between the scientific assessment hazard 
and probability of occurrence and the perception of risk. Wes studied changes in European perceptions about biotechnology and thinks that he can 
explain them with this model.  
Wes used descriptions of attitudes about risks in poultry production, nuclear power, smoking, travel to illustrate the existence of predisposing anxiety 
that varies from society to society.   The existence of the differences implies the action of interrelationships in the formation of perceptions. He 
pointed out the risk perception can be broken down into 3 component questions: what is the nature of the risk, what should I think about it, and what 
should I do. Perceptions are formed in a multi-cultural community of meaning.  He said that we can think of interaction within the communities 
creating “rivaling rationalities,” with all having equivalent validity.
factors Influencing the perception of risk (After Kasperson)
Factor	 	 	 	 	 Increase	Public	Confidence	 															Decrease	Public	Confidence
fatalities, injuries, disease exposure  Scattered and random    grouped
fatalities, injuries, disease exposure  Voluntary     Involuntary
effects on Children    Non-specific     Specific
manifestation    Immediate                 delayed
effects on the future   None          possibly many
trust in Institutions   Yes       No
media Attention    Little                   Very much
origin     Nature or god         Human action
equity of risk and benefits   even      Inequitable 
Uncertainty    Scientifically known, certain, uncontested  Scientifically unknown, uncertain, 
           or contested
Wes’ study involved interviews with leaders of four European activist organizations. The objective was to see if their actions fit the factors listed in 
the table as they attempted to change public opinion about biotechnology
The interviews established that the organizations had used surveys and focus groups to determine which factors would be most likely to influence 
public perceptions.  The leaders of the groups selected 5 factors that they though would most effectively amplify public reaction:  Effects on children, 
the manifestation of effects in the future, future effects, the origin of biotechnology, and uncertainty.  Activities were designed around these themes.  
The leaders of the organizations think that three factors influenced the public: lack of control, unknown future effects and the artificial origin of the 
technology. These factors correspond nicely with the precautionary principle. 
Various shorts of conflict can emerge: conflict over the nature of particular facts, conflicts over the appropriate means to validate facts 
(epistemology), and conflicts based on value-systems.  In addition there can be conflicts about whether facts are substantive or normative (carrying 
ethical obligations).   
Wes categorized actions that can influence perception of risk: contesting facts, influencing the individual’s retention of facts (repetition), and 
establishing linkage to values.  Based on Wes’ observation, risk amplification works if the agent can find a resonant message.
Wes concluded by emphasizing that risk perception should be thought of as subjective; science should be held accountable for biotechnology because 
it does have the potential to create permanent and unpredictable changes in the biological environment; and Non-government organizations serve as 
useful “speed bumps,” to slow the introduction of technology until it is better understood.
the Social Amplification of risk
One can divide attitudes to biotechnology into three broad groups, based on their association with types of ethics: utilitarian, individual rights 
and virtue ethics.  Virtue ethics is the most diverse of the three types.  It assumes that habits of thought are important to the selection behaviors 
by individuals in communities, more important than what we normally understand as firm moral rules. Communities and elite groups in the 
community are involved in educating individuals with the habits will benefit both the individual and the community. Individuals interact with 
their communities to mold new habits of behavior as the environment changes and old habits are no longer adapted. 
Given this understanding of the role of the community, virtue ethics must, almost by definition, assume that the individual has less immediate 
influence in his choices because some actions are excluded by custom. Some kinds of virtue ethics make up for immediate restrictions by giving 
the individual more influence on selection of future customs.  Other communities the ability to change is restricted by tradition and religion.  
The role of community in human behavior is inherently a chicken and egg, reciprocal, situation. Man creates ideas at times, and at times ideas 
remake human character. This seems obvious when the issue isn’t too sensitive, but becomes very sensitive when discussing basic cultural beliefs 
and religion.      
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Seed Science Center
Ames, Iowa 50011-3228
NoNprofIt org.
U.S. poStAge 
pAId
permIt No.200
AmeS, IowA
3rd Anual BIGMAP Symposium
 
the Iowa State University Biosafety Institute for genetically 
modified Agricultural products (BIgmAp) Symposium 
will be held April 18, 2006 at the gateway Center, Ames, 
Iowa. this year’s symposium addresses “Understanding 
and Communicating Issues in Agricultural Biotechnology” 
and will feature two half-day sessions with presentations 
from experts addressing science, regulation, and 
communication. 
 
further information and on-line registration can be found 
at 
http://www.ucs.iastate.edu/mnet/bigmap/home.html 
